Plant Bioscience Enters Licensing AgreementMay 16, 2008
Plant Bioscience Limited, a UK based independent intellectual property (IP) management and technology transfer corporation, announced that it has entered a license agreement with a biotech company in respect to the flavodoxin technology for enhancing crop performance. The technology was developed by scientists from the Universidad Nacional de Rosario in Argentina.
Flavodoxin is a protein from cyanobacteria that provides plants with tolerance to iron starvation and abiotic stress. The protein prevents disruption of the plant photosynthetic machinery under stress conditions by acting as an alternative electron carrier. Flavodoxin has been shown to work well in numerous plant species.
Under the agreement, the undisclosed biotech company will be given exclusive commercial rights to use the technology to ten crop species, including maize, soybean, oilseed rape, cotton and rice.
The Crop Biotech Update is a weekly newsletter of ISAAA, a non-for-profit organization. The CBU is distributed for free to over 23,000 subscribers worldwide to inform them about the key developments in biosciences, especially in agricultural biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
News from Around the World
- FAO Sees Strong Signs of Record Rice Production
- UN Conference Discusses Liability Rules and Redress
- New Ideas to Boost World Tea Market
- Uganda Puts Up Biotech Center for Cassava
- ARS Releases Nematode, Virus Resistant Peanut Variety
- GE Approaches to Improve Nitrogen Use Efficiency
- DuPont and Genencor Form Cellulosic Ethanol Venture
- Taiwan Implements Stacks Registration
- ABARE Report : Australia to Benefit from GM Crops
- Pakistan Environment Minister Calls for GMOs in Agriculture
- Agricultural Scientists in Pakistan Urged to Develop Biotech Varieties
- Bayer Launches Disease Resistant Rice
- ICRISAT: Sweet Sorghum Could be the Miracle Biofuel Crop
- DEFRA Approves GM Potato Trial
- PRRI Open Letter to EC Members
- German Ag-Industries Say EU Biotech Policy Affecting Supply Problem
- Plant Bioscience Enters Licensing Agreement
- Starch Degrading Enzyme from GM Potatoes
- GM Tobacco Expressing Cervical Cancer Vaccine
- Brassinosteroids and Water Stress Response
- CropLife International Online Database on Agri-biotech Benefits
Subscribe to CBU: